Damien Foundation Bangladesh   Report issue

Foundation Phase 3
Founded: Faridpur Bangladesh (1997)

Organization Overview

First Clinical Trial
2006
NCT00406861
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Damien Foundation | Damien Foundation Comoros

Active Ingredients

Drugs in Phase 3 Trials (4)

bedaquiline (sirturo) (2 trials)

isoniazid (nydrazid) (1 trial)

levofloxacin (levaquin) (1 trial)

rifampin (5 trials)

Drugs in Other Trials (1)

montelukast (singulair) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leprosy (Phase 3)

Tuberculosis (Phase 3)

Tuberculosis, Pulmonary (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 5